Cargando…
Q6, a novel hypoxia-targeted drug, regulates hypoxia-inducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma
Tumor hypoxia underlies treatment failure and yields more aggressive and metastatic cancer phenotypes. Although therapeutically targeting these hypoxic environments has been proposed for many years, to date no approaches have shown the therapeutic value to gain regulatory approval. Here, we demonstr...
Autores principales: | Liu, Xiao-Wen, Cai, Tian-yu, Zhu, Hong, Cao, Ji, Su, Yi, Hu, Yong-zhou, He, Qiao-Jun, Yang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389865/ https://www.ncbi.nlm.nih.gov/pubmed/24220190 http://dx.doi.org/10.4161/auto.26838 |
Ejemplares similares
-
Hypoxia-Targeted Drug Q6 Induces G2-M Arrest and Apoptosis via Poisoning Topoisomerase II under Hypoxia
por: Chang, Linlin, et al.
Publicado: (2015) -
Autophagy contributes to regulation of the hypoxia response during submergence in Arabidopsis thaliana
por: Chen, Liang, et al.
Publicado: (2015) -
Hypoxia induces autophagy in cardiomyocytes via a hypoxia-inducible factor 1-dependent mechanism
por: GUI, LAN, et al.
Publicado: (2016) -
Extracellular vesicles from hypoxia-preconditioned mesenchymal stem cells alleviates myocardial injury by targeting thioredoxin-interacting protein-mediated hypoxia-inducible factor-1α pathway
por: Mao, Cheng-Yu, et al.
Publicado: (2022) -
Telmisartan attenuates kidney apoptosis and autophagy-related protein expression levels in an intermittent hypoxia mouse model
por: Zhang, Xiao-Bin, et al.
Publicado: (2018)